Lotus Pharmaceutical Co., Ltd.(TW:1795)
NT$156.00-10.50 (-6.31%)
TW:1795
Lotus Pharmaceutical Co., Ltd. Revenue
NT$156.00
At close:-10.50 (-6.31%)
Lotus Pharmaceutical Co., Ltd. (1795) Revenue
Lotus Pharmaceutical Co., Ltd. Revenue
Lotus Pharmaceutical Co., Ltd. had a revenue of 8.81B in the quarter ending Jun 30, 2026, with 1.90%. This bring the company's revenue in the last twelve months to 28.49B, Increased 16.63%. In the fiscal year ending Dec 31, 2025, Lotus Pharmaceutical Co., Ltd. had annual revenue of 20.51B with 10.36% growth.
- Revenue (ttm)
- 28.49B
- Revenue Growth
- 48.98%
- P/S Ratio
- 2.16
- Revenue/Employee
- TWD 18,661,942
- Employees
- 1,099
- Market Cap
- TWD 44.28B
Revenue Chart
Lotus Pharmaceutical Co., Ltd. Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 20.51B | 1.93B | 10.36% |
| Dec 31, 2024 | 18.58B | 1.63B | 9.59% |
| Dec 31, 2023 | 16.96B | 2.33B | 15.89% |
| Dec 31, 2022 | 14.63B | 1.98B | 15.68% |
| Dec 31, 2021 | 12.65B | 1.92B | 17.90% |
| Dec 31, 2020 | 10.73B | 1.55B | 16.94% |
| Dec 31, 2019 | 9.17B | 2.75B | 42.71% |
| Dec 31, 2018 | 6.43B | 5.13M | 0.08% |
| Dec 31, 2017 | 6.42B | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.